CD36 genetic variants were also identified in humans characterized by high serum triglycerides, low HDL levels, and hyperglycemia with insulin resistance, all considered clinical features of metabolic syndrome [75,92,93]. This evidence concerns the gene CD36 and metabolic syndrome.